文献速递烧伤

可溶性ST2预测吸入性损伤患者肺炎:一项初步研究

Soluble suppression of tumorigenicity-2 predicts pneumonia in patients with inhalation injury: Results of a pilot study.
PubMed 文献 · Burns · 2020-10-21

该研究为单中心前瞻性观察性队列初步研究的二次分析,纳入24例疑似吸入性损伤的成人患者,在入院24小时内检测血浆生物标志物。结果显示,肺炎组sST2、IL33和IL8水平显著更高,sST2预测肺炎的AUROC为0.929, cutoff值≥2825 ng/mL时敏感度75%、特异度100%。

要点

  • 吸入性损伤患者入院24小时内血浆sST2升高与肺炎发生相关。
  • sST2预测肺炎的AUROC为0.929, cutoff值≥2825 ng/mL时特异度100%。
  • sST2≥2825 ng/mL者肺炎风险比为7.14。

核心结论

  • 入院24小时内血浆sST2可预测吸入性损伤患者肺炎的发生。

研究设计与样本

  • 单中心前瞻性观察性队列初步研究的二次分析,2015-2017年于Vall d'Hebron大学医院烧伤科进行,纳入24例疑似吸入性损伤的成人患者。

主要发现

  • 24例患者中8例(33.3%)发生肺炎,中位发生时间为住院7(4-8)天。
  • 肺炎组入院第1天血浆sST2为2853(2356-3351)ng/mL,高于无肺炎组的1352(865-1839)ng/mL(p < 0.001)。
  • 肺炎组IL33为1.95(1.31-2.59)pg/mL,高于无肺炎组的1.26(1.07-1.45)pg/mL(p = 0.002)。
  • 肺炎组IL8为325.7(221.6-430.0)pg/mL,高于无肺炎组的174.1(95.2-253.0)pg/mL(p = 0.017)。
  • sST2预测肺炎的AUROC为0.929(95%CI 0.818-1.000), cutoff值≥2825 ng/mL时敏感度75%、特异度100%,风险比7.14(95%CI 1.56-32.61;p = 0.016)。

关键数值与推荐

  • sST2 cutoff值≥2825 ng/mL用于预测吸入性损伤后肺炎,敏感度75%、特异度100%。

临床怎么用

  • 对吸入性损伤患者,入院24小时内检测血浆sST2可能有助于识别肺炎高危患者。

局限性

  • 本研究为单中心初步研究,样本量小(24例),结论需更大样本验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Several mechanisms play a role in the development of pneumonia after inhalation injury. Our aim was to analyze whether higher concentrations of inflammatory markers or of biomarkers of epithelial injury are associated with a higher incidence of pneumonia in patients with inhalation injury. MATERIAL AND METHODS: Secondary analysis of a single-center prospective observational cohort pilot study, performed over a two-year period (2015-2017) at the Burns Unit of the Plastic and Reconstructive Surgery Department of Vall d'Hebron University Hospital. All patients aged 18 with suspected inhalation injury undergoing admission to the Burns Unit were included. Plasma biomarkers of the lung epithelium (RAGE and SP-D), inflammation markers (IL6, IL8), and IL33, as well as soluble suppression of tumorigenicity-2 (sST2) levels, were measured within the first 24 h of admission. RESULTS: Twenty-four patients with inhalation injury were included. Eight (33.3%) developed pneumonia after a median of 7 (4-8) days of hospital stay. Patients with pneumonia presented higher plasma concentrations of sST2 (2853 [2356-3351] ng/mL vs 1352 [865-1839] ng/mL; p < 0.001), IL33 (1.95 [1.31-2.59] pg/mL vs 1.26 [1.07-1.45] pg/mL; p = 0.002) and IL8 (325.7 [221.6-430.0] pg/mL vs 174.1 [95.2-253.0] pg/mL; p = 0.017) on day 1 of inclusion. Plasma sST2 concentration in the first 24 h demonstrated excellent diagnostic accuracy for predicting the occurrence of pneumonia in patients with smoke inhalation (AUROC 0.929 [95%CI 0.818-1.000]). A cutoff point of ≥2825 ng/mL for sST2 had a sensitivity of 75% and a specificity of 100%. The risk ratio of pneumonia in patients with sST2 ≥ 2825 ng/mL was 7.14 ([95% CI 1.56-32.61]; p = 0.016). CONCLUSIONS: Plasma sST2 in the first 24 h of admission predicts the occurrence of pneumonia in patients with inhalation injury.

来源:Burns,查看原文。版权归原作者所有。

引用

  1. Ruiz-Castilla M, Dos Santos B, Vizcaíno C, et al. Soluble suppression of tumorigenicity-2 predicts pneumonia in patients with inhalation injury: Results of a pilot study. Burns. 2020. PMID: 33143991. doi:10.1016/j.burns.2020.10.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。